Litcius/Paper detail

Scaffolding mechanism of arrestin-2 in the cRaf/MEK1/ERK signaling cascade

Changxiu Qu, Ji Young Park, Min Woo Yun, Qing‐tao He, Fan Yang, Kiae Kim, Donghee Ham, Rui-rui Li, T.M. Iverson, Vsevolod V. Gurevich, Jin‐Peng Sun, Ka Young Chung

2021Proceedings of the National Academy of Sciences49 citationsDOIOpen Access PDF

Abstract

Arrestins were initially identified for their role in homologous desensitization and internalization of G protein-coupled receptors. Receptor-bound arrestins also initiate signaling by interacting with other signaling proteins. Arrestins scaffold MAPK signaling cascades, MAPK kinase kinase (MAP3K), MAPK kinase (MAP2K), and MAPK. In particular, arrestins facilitate ERK1/2 activation by scaffolding ERK1/2 (MAPK), MEK1 (MAP2K), and Raf (MAPK3). However, the structural mechanism underlying this scaffolding remains unknown. Here, we investigated the mechanism of arrestin-2 scaffolding of cRaf, MEK1, and ERK2 using hydrogen/deuterium exchange-mass spectrometry, tryptophan-induced bimane fluorescence quenching, and NMR. We found that basal and active arrestin-2 interacted with cRaf, while only active arrestin-2 interacted with MEK1 and ERK2. The ATP binding status of MEK1 or ERK2 affected arrestin-2 binding; ATP-bound MEK1 interacted with arrestin-2, whereas only empty ERK2 bound arrestin-2. Analysis of the binding interfaces suggested that the relative positions of cRaf, MEK1, and ERK2 on arrestin-2 likely facilitate sequential phosphorylation in the signal transduction cascade.

Topics & Concepts

Scaffold proteinMAPK/ERK pathwayCell biologyMechanism (biology)ScaffoldCascadePhosphorylationChemistryArrestinSignal transductionBiologyMedicineG protein-coupled receptorPhysicsBiomedical engineeringChromatographyQuantum mechanicsReceptor Mechanisms and SignalingMelanoma and MAPK PathwaysComputational Drug Discovery Methods